PDF(Pubmed)
Abstract：
OBJECTIVE: To measure the prevalence of alcohol and/or other drug (AOD) detections in suspected major trauma patients with non-transport injuries who presented to an adult major trauma centre.
METHODS: This registry-based cohort study examined the prevalence of AOD detections in patients aged ≥18 years who: (i) sustained non-transport injuries; and (ii) met predefined trauma call-out criteria and were therefore managed by an interdisciplinary trauma team between 1 July 2021 and 31 December 2022. Prevalence was measured using routine in-hospital blood alcohol and urine drug screens.
RESULTS: A total of 1469 cases met the inclusion criteria. Of cases with a valid blood test (n = 1248, 85.0%), alcohol was detected in 313 (25.1%) patients. Of the 733 (49.9%) cases with urine drug screen results, cannabinoids were most commonly detected (n = 103, 14.1%), followed by benzodiazepines (n = 98, 13.4%), amphetamine-type substances (n = 80, 10.9%), opioids (n = 28, 3.8%) and cocaine (n = 17, 2.3%). Alcohol and/or at least one other drug was detected in 37.4% (n = 472) of cases with either a blood alcohol or urine drug test completed (n = 1263, 86.0%). Multiple substances were detected in 16.6% (n = 119) of cases with both blood alcohol and urine drug screens (n = 718, 48.9%). Detections were prevalent in cases of interpersonal violence (n = 123/179, 68.7%) and intentional self-harm (n = 50/106, 47.2%), and in those occurring on Friday and Saturday nights (n = 118/191, 61.8%).
CONCLUSIONS: AOD detections were common in trauma patients with non-transport injury causes. Population-level surveillance is needed to inform prevention strategies that address AOD use as a significant risk factor for serious injury.
METHODS: This registry-based cohort study examined the prevalence of AOD detections in patients aged ≥18 years who: (i) sustained non-transport injuries; and (ii) met predefined trauma call-out criteria and were therefore managed by an interdisciplinary trauma team between 1 July 2021 and 31 December 2022. Prevalence was measured using routine in-hospital blood alcohol and urine drug screens.
RESULTS: A total of 1469 cases met the inclusion criteria. Of cases with a valid blood test (n = 1248, 85.0%), alcohol was detected in 313 (25.1%) patients. Of the 733 (49.9%) cases with urine drug screen results, cannabinoids were most commonly detected (n = 103, 14.1%), followed by benzodiazepines (n = 98, 13.4%), amphetamine-type substances (n = 80, 10.9%), opioids (n = 28, 3.8%) and cocaine (n = 17, 2.3%). Alcohol and/or at least one other drug was detected in 37.4% (n = 472) of cases with either a blood alcohol or urine drug test completed (n = 1263, 86.0%). Multiple substances were detected in 16.6% (n = 119) of cases with both blood alcohol and urine drug screens (n = 718, 48.9%). Detections were prevalent in cases of interpersonal violence (n = 123/179, 68.7%) and intentional self-harm (n = 50/106, 47.2%), and in those occurring on Friday and Saturday nights (n = 118/191, 61.8%).
CONCLUSIONS: AOD detections were common in trauma patients with non-transport injury causes. Population-level surveillance is needed to inform prevention strategies that address AOD use as a significant risk factor for serious injury.
摘要：
目的：评估到成人重大创伤中心就诊的疑似重大创伤患者的酒精和/或其他药物（AOD）检测的患病率。
方法：这项基于注册表的队列研究检查了年龄≥18岁的患者中AOD检测的患病率，这些患者：（i）持续非运输损伤；（ii）符合预定义的创伤排除标准，因此在2021年7月1日至2022年12月31日之间由跨学科创伤团队管理。使用常规院内血液酒精和尿液药物筛查来测量患病率。
结果：共1469例符合纳入标准。在血液检查有效的病例中（n=1248，85.0％），313例(25.1%)患者检测到酒精。在733例(49.9%)尿液药物筛查结果中,大麻素是最常见的检测（n=103，14.1%），其次是苯二氮卓类药物（n=98，13.4%），苯丙胺类物质(n=80，10.9%)，阿片类药物（n=28，3.8％）和可卡因（n=17，2.3％）。在完成血液酒精或尿液药物测试的病例中，有37.4％（n=472）检测到酒精和/或至少一种其他药物（n=1263，86.0％）。在血液酒精和尿液药物筛查的病例中，有16.6％（n=119）检测到多种物质（n=718，48.9％）。在人际暴力(n=123/179,68.7%)和故意自残(n=50/106,47.2%)案件中,以及周五和周六晚上发生的事件(n=118/191，61.8%)。
结论：AOD检测在非运输损伤原因的创伤患者中很常见。需要进行人群水平的监测，以告知预防策略，将AOD的使用作为严重伤害的重要风险因素。
方法：这项基于注册表的队列研究检查了年龄≥18岁的患者中AOD检测的患病率，这些患者：（i）持续非运输损伤；（ii）符合预定义的创伤排除标准，因此在2021年7月1日至2022年12月31日之间由跨学科创伤团队管理。使用常规院内血液酒精和尿液药物筛查来测量患病率。
结果：共1469例符合纳入标准。在血液检查有效的病例中（n=1248，85.0％），313例(25.1%)患者检测到酒精。在733例(49.9%)尿液药物筛查结果中,大麻素是最常见的检测（n=103，14.1%），其次是苯二氮卓类药物（n=98，13.4%），苯丙胺类物质(n=80，10.9%)，阿片类药物（n=28，3.8％）和可卡因（n=17，2.3％）。在完成血液酒精或尿液药物测试的病例中，有37.4％（n=472）检测到酒精和/或至少一种其他药物（n=1263，86.0％）。在血液酒精和尿液药物筛查的病例中，有16.6％（n=119）检测到多种物质（n=718，48.9％）。在人际暴力(n=123/179,68.7%)和故意自残(n=50/106,47.2%)案件中,以及周五和周六晚上发生的事件(n=118/191，61.8%)。
结论：AOD检测在非运输损伤原因的创伤患者中很常见。需要进行人群水平的监测，以告知预防策略，将AOD的使用作为严重伤害的重要风险因素。
